Compare Medpace Holdings Inc (MEDP) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Southern Copper Corp — how do they compare? Medpace Holdings Inc trades at $532.42 (market cap $15.08B), while Southern Copper Corp trades at $187.06 (market cap $146.07B). The key difference: Southern Copper Corp is far larger — about 9.7× Medpace Holdings Inc's market cap, and Southern Copper Corp pays a 2.28% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | SCCO | |
|---|---|---|
Market Cap | $15.08B | $146.07B |
Sector | Technology | Basic Materials |
52-Week High | $620.59 | $218.85 |
52-Week Low | $308.88 | $90.54 |
Enterprise Value | $14.55B | $148.12B |
Dividend Yield | — | 2.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Southern Copper (SCCO) trades at $175.27, up 1.62% on the day, with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with revenue growth from $11.4B in 2024 to $13.4B in 2025 and net income rising to $4.3B. Valuation ratios are elevated with a P/E of 29.2 and P/B of 12.2. A recent dividend of $1.00 was declared, payable May 29, 2026, alongside a minor stock split.
Outlook is mixed: robust profitability and copper demand from AI infrastructure support growth, but high valuation and bearish analyst consensus pose risks. The consensus price target is $152.79, below the current price, indicating potential downside. Key risks include commodity price volatility and debt levels, though operational cash flow remains strong at $4.75B in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
